Table 2.
Characteristics of patients and hospital stays according to the place of the statin-drug interaction occurrence.
|
|
Interaction only during community consumption (n=1779) | Interaction only during hospital consumption (n=2326) | Interaction during community and also hospital consumption (n=1474) | No interaction (n=11,227) | P value | ||
| Sex (men), n (%) | 1132 (63.63) | 1521 (65.39) | 1008 (68.39) | 6997 (62.32) | <.001 | ||
| Age (≥65 years), n (%) | 1394 (78.36) | 1750 (75.24) | 1215 (82.43) | 7739 (68.93) | <.001 | ||
| Unscheduled admission, n (%) | 698 (39.24) | 926 (39.81) | 544 (36.91) | 3837 (34.18) | <.001 | ||
| Type of care, n (%) | <.001 | ||||||
|
|
Medical care | 1233 (69.31) | 1149 (49.39) | 787 (53.39) | 6030 (53.71) |
|
|
|
|
Surgery | 546 (30.69) | 1177 (50.6) | 687 (46.61) | 5197 (46.29) |
|
|
| Length of stay (days), mean (SD) | 8.3 (10.4) | 11.9 (15.8) | 8.4 (10.1) | 7.6 (8.2) | <.001 | ||
| Intensive care unit admission, n (%) | 94 (5.28) | 742 (31.9) | 260 (17.64) | 2156 (19.2) | <.001 | ||
| Diagnosis-related group severity, n (%) | <.001 | ||||||
|
|
1 (least severe) | 1314 (73.86) | 692 (29.75) | 565 (38.33) | 7070 (62.97) |
|
|
|
|
2 | 177 (9.95) | 673 (28.93) | 388 (26.32) | 2015 (17.95) |
|
|
|
|
3 | 197 (11.07) | 729 (31.34) | 396 (26.87) | 1692 (15.07) |
|
|
|
|
4 (most severe) | 91 (5.12) | 232 (9.97) | 125 (8.48) | 450 (4) |
|
|
| In-hospital mortality, n (%) | 12 (0.67) | 24 (1.03) | 31 (2.1) | 87 (0.77) | <.001 | ||